Virax Biolabs Group Limited (VRAX:NASDAQ) jumped higher at $3.49, representing a gain of 41.3%. On Tue, Sep 20, 2022, VRAX:NASDAQ hit a New 2-Week Intraday High of $3.74. The stock appeared on our News Catalysts scanner on Tue, Sep 20, 2022 at 10:24 AM in the 'BIOTECH' category. From Tue, Sep 06, 2022, the stock recorded 30.00% Up Days and 27.27% Green Days
The stock spiked on Thu, Sep 01, 2022 at $6.1 with a volume of 21M+.
About Virax Biolabs Group Limited (VRAX:NASDAQ)
Virax Biolabs Group Ltd is a innovative biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases with a particular interest in the field of...
Top 10 Gainers:
- Amprius Technologies Inc. (AMPX:NYSE), 86.44%
- Powerbridge Technologies Co., Ltd. (PBTS:NASDAQ), 60.62%
- NeuroBo Pharmaceuticals, Inc. (NRBO:NASDAQ), 42.4%
- Virax Biolabs Group Limited (VRAX:NASDAQ), 41.3%
- Cassava Sciences, Inc. (SAVA:NASDAQ), 28.42%
- Trxade Group, Inc. (MEDS:NASDAQ), 27.7%
- Mobile Global Esports Inc. (MGAM:NASDAQ), 26.45%
- SaverOne 2014 Ltd. (SVRE:NASDAQ), 22.4%
- Yunji Inc. (YJ:NASDAQ), 20.19%
- Fennec Pharmaceuticals Inc. (FENC:NASDAQ), 15.78%